메뉴 건너뛰기




Volumn 6, Issue 6, 2017, Pages

Causal effect of plasminogen activator inhibitor type 1 on coronary heart disease

(484)  Song, Ci a,b   Burgess, Stephen c   Eicher, John D a,b   O'Donnell, Christopher J a,d   Johnson, Andrew D a,b   Huang, Jie e   Sabater Lleal, Maria e   Asselbergs, Folkert W e   Tregouet, David e   Shin, So Youn e   Ding, Jingzhong e   Baumert, Jens e   Oudot Mellakh, Tiphaine e   Folkersen, Lasse e   Smith, Nicholas L e   Williams, Scott M e   Ikram, Mohammad A e   Kleber, Marcus E e   Becker, Diane M e   Truong, Vinh e   more..

e NONE

Author keywords

Coronary heart disease; Genome wide association study; Mendelian randomization; Plasminogen activator inhibitor type 1; Single nucleotide polymorphism

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; PLASMINOGEN ACTIVATOR INHIBITOR 1; BIOLOGICAL MARKER; HIGH DENSITY LIPOPROTEIN; SERPINE1 PROTEIN, HUMAN;

EID: 85020419920     PISSN: None     EISSN: 20479980     Source Type: Journal    
DOI: 10.1161/JAHA.116.004918     Document Type: Article
Times cited : (101)

References (58)
  • 1
    • 0030997665 scopus 로고    scopus 로고
    • Human plasminogen activator inhibitor-1 (PAI-1) deficiency: characterization of a large kindred with a null mutation in the PAI-1 gene
    • Fay WP, Parker AC, Condrey LR, Shapiro AD. Human plasminogen activator inhibitor-1 (PAI-1) deficiency: characterization of a large kindred with a null mutation in the PAI-1 gene. Blood. 1997;90:204-208.
    • (1997) Blood , vol.90 , pp. 204-208
    • Fay, W.P.1    Parker, A.C.2    Condrey, L.R.3    Shapiro, A.D.4
  • 2
    • 0026538755 scopus 로고
    • Familial thrombophila associated with high levels of plasminogen activator inhibitor
    • Patrassi GM, Sartori MT, Saggiorato G, Boeri G, Girolami A. Familial thrombophila associated with high levels of plasminogen activator inhibitor. Fibrinolysis. 1992;6:99-103.
    • (1992) Fibrinolysis , vol.6 , pp. 99-103
    • Patrassi, G.M.1    Sartori, M.T.2    Saggiorato, G.3    Boeri, G.4    Girolami, A.5
  • 3
    • 0021889294 scopus 로고
    • Two different mechanisms in patients with venous thrombosis and defective fibrinolysis: low concentration of plasminogen activator or increased concentration of plasminogen activator inhibitor
    • Nilsson IM, Ljungner H, Tengborn L. Two different mechanisms in patients with venous thrombosis and defective fibrinolysis: low concentration of plasminogen activator or increased concentration of plasminogen activator inhibitor. BMJ. 1985;290:1453-1456.
    • (1985) BMJ , vol.290 , pp. 1453-1456
    • Nilsson, I.M.1    Ljungner, H.2    Tengborn, L.3
  • 5
    • 0000150727 scopus 로고
    • The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group
    • Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med. 1995;333:1581-1587.
    • (1995) N Engl J Med , vol.333 , pp. 1581-1587
  • 6
    • 84955518089 scopus 로고    scopus 로고
    • Plasminogen activator inhibitor-1 and type 2 diabetes: a systematic review and meta-analysis of observational studies
    • Yarmolinsky J, Bordin Barbieri N, Weinmann T, Ziegelmann PK, Duncan BB, Ines Schmidt M. Plasminogen activator inhibitor-1 and type 2 diabetes: a systematic review and meta-analysis of observational studies. Sci Rep. 2016;6:17714.
    • (2016) Sci Rep , vol.6 , pp. 17714
    • Yarmolinsky, J.1    Bordin Barbieri, N.2    Weinmann, T.3    Ziegelmann, P.K.4    Duncan, B.B.5    Ines Schmidt, M.6
  • 8
    • 0028832052 scopus 로고
    • Association of fibrinolytic parameters with early atherosclerosis. The ARIC Study. Atherosclerosis Risk in Communities Study
    • Salomaa V, Stinson V, Kark JD, Folsom AR, Davis CE, Wu KK. Association of fibrinolytic parameters with early atherosclerosis. The ARIC Study. Atherosclerosis Risk in Communities Study. Circulation. 1995;91:284-290.
    • (1995) Circulation , vol.91 , pp. 284-290
    • Salomaa, V.1    Stinson, V.2    Kark, J.D.3    Folsom, A.R.4    Davis, C.E.5    Wu, K.K.6
  • 12
    • 77956022279 scopus 로고    scopus 로고
    • Plasma levels of fibrinolytic proteins and the risk of myocardial infarction in men
    • Meltzer ME, Doggen CJ, de Groot PG, Rosendaal FR, Lisman T. Plasma levels of fibrinolytic proteins and the risk of myocardial infarction in men. Blood. 2010;116:529-536.
    • (2010) Blood , vol.116 , pp. 529-536
    • Meltzer, M.E.1    Doggen, C.J.2    de Groot, P.G.3    Rosendaal, F.R.4    Lisman, T.5
  • 13
    • 68149176897 scopus 로고    scopus 로고
    • Changes in plasma C-reactive protein and hemostatic factors prior to and after a first myocardial infarction with a median follow-up time of 8 years
    • Thogersen AM, Nilsson TK, Weinehall L, Boman K, Eliasson M, Hallmans G, Jansson JH. Changes in plasma C-reactive protein and hemostatic factors prior to and after a first myocardial infarction with a median follow-up time of 8 years. Blood Coagul Fibrinolysis. 2009;20:340-346.
    • (2009) Blood Coagul Fibrinolysis , vol.20 , pp. 340-346
    • Thogersen, A.M.1    Nilsson, T.K.2    Weinehall, L.3    Boman, K.4    Eliasson, M.5    Hallmans, G.6    Jansson, J.H.7
  • 14
    • 30944441643 scopus 로고    scopus 로고
    • Which hemostatic markers add to the predictive value of conventional risk factors for coronary heart disease and ischemic stroke?
    • Smith A, Patterson C, Yarnell J, Rumley A, Ben-Shlomo Y, Lowe G. Which hemostatic markers add to the predictive value of conventional risk factors for coronary heart disease and ischemic stroke? The Caerphilly Study Circulation. 2005;112:3080-3087.
    • (2005) The Caerphilly Study Circulation , vol.112 , pp. 3080-3087
    • Smith, A.1    Patterson, C.2    Yarnell, J.3    Rumley, A.4    Ben-Shlomo, Y.5    Lowe, G.6
  • 16
    • 0035051534 scopus 로고    scopus 로고
    • Prospective study of fibrinolytic factors and incident coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) Study
    • Folsom AR, Aleksic N, Park E, Salomaa V, Juneja H, Wu KK. Prospective study of fibrinolytic factors and incident coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) Study. Arterioscler Thromb Vasc Biol. 2001;21:611-617.
    • (2001) Arterioscler Thromb Vasc Biol , vol.21 , pp. 611-617
    • Folsom, A.R.1    Aleksic, N.2    Park, E.3    Salomaa, V.4    Juneja, H.5    Wu, K.K.6
  • 19
    • 0032564442 scopus 로고    scopus 로고
    • High plasminogen activator inhibitor and tissue plasminogen activator levels in plasma precede a first acute myocardial infarction in both men and women: evidence for the fibrinolytic system as an independent primary risk factor
    • Thogersen AM, Jansson JH, Boman K, Nilsson TK, Weinehall L, Huhtasaari F, Hallmans G. High plasminogen activator inhibitor and tissue plasminogen activator levels in plasma precede a first acute myocardial infarction in both men and women: evidence for the fibrinolytic system as an independent primary risk factor. Circulation. 1998;98:2241-2247.
    • (1998) Circulation , vol.98 , pp. 2241-2247
    • Thogersen, A.M.1    Jansson, J.H.2    Boman, K.3    Nilsson, T.K.4    Weinehall, L.5    Huhtasaari, F.6    Hallmans, G.7
  • 21
    • 84875854218 scopus 로고    scopus 로고
    • The impact of cigarette smoking on 24-hour blood pressure, inflammatory and hemostatic activity, and cardiovascular risk in Japanese hypertensive patients
    • Yano Y, Hoshide S, Shimada K, Kario K. The impact of cigarette smoking on 24-hour blood pressure, inflammatory and hemostatic activity, and cardiovascular risk in Japanese hypertensive patients. J Clin Hypertens. 2013;15:234-240.
    • (2013) J Clin Hypertens , vol.15 , pp. 234-240
    • Yano, Y.1    Hoshide, S.2    Shimada, K.3    Kario, K.4
  • 23
    • 44149116748 scopus 로고    scopus 로고
    • Assessment of coronary heart disease risk by combined analysis of coagulation factors
    • Aleksic N, Wang YW, Ahn C, Juneja HS, Folsom AR, Wu KK. Assessment of coronary heart disease risk by combined analysis of coagulation factors. Atherosclerosis. 2008;198:294-300.
    • (2008) Atherosclerosis , vol.198 , pp. 294-300
    • Aleksic, N.1    Wang, Y.W.2    Ahn, C.3    Juneja, H.S.4    Folsom, A.R.5    Wu, K.K.6
  • 24
    • 42249114694 scopus 로고    scopus 로고
    • Plasminogen activator inhibitor-1 activity in type 2 diabetes: a different relationship with coronary heart disease and diabetic retinopathy
    • Brazionis L, Rowley K, Jenkins A, Itsiopoulos C, O'Dea K. Plasminogen activator inhibitor-1 activity in type 2 diabetes: a different relationship with coronary heart disease and diabetic retinopathy. Arterioscler Thromb Vasc Biol. 2008;28:786-791.
    • (2008) Arterioscler Thromb Vasc Biol , vol.28 , pp. 786-791
    • Brazionis, L.1    Rowley, K.2    Jenkins, A.3    Itsiopoulos, C.4    O'Dea, K.5
  • 25
    • 84885840876 scopus 로고    scopus 로고
    • Mendelian randomization analysis with multiple genetic variants using summarized data
    • Burgess S, Butterworth A, Thompson SG. Mendelian randomization analysis with multiple genetic variants using summarized data. Genet Epidemiol. 2013;37:658-665.
    • (2013) Genet Epidemiol , vol.37 , pp. 658-665
    • Burgess, S.1    Butterworth, A.2    Thompson, S.G.3
  • 27
    • 84903695006 scopus 로고    scopus 로고
    • The association between plasminogen activator inhibitor type 1 (PAI-1) levels, PAI-1 4G/5G polymorphism, and myocardial infarction: a Mendelian randomization meta-analysis
    • Nikolopoulos GK, Bagos PG, Tsangaris I, Tsiara CG, Kopterides P, Vaiopoulos A, Kapsimali V, Bonovas S, Tsantes AE. The association between plasminogen activator inhibitor type 1 (PAI-1) levels, PAI-1 4G/5G polymorphism, and myocardial infarction: a Mendelian randomization meta-analysis. Clin Chem Lab Med. 2014;52:937-950.
    • (2014) Clin Chem Lab Med , vol.52 , pp. 937-950
    • Nikolopoulos, G.K.1    Bagos, P.G.2    Tsangaris, I.3    Tsiara, C.G.4    Kopterides, P.5    Vaiopoulos, A.6    Kapsimali, V.7    Bonovas, S.8    Tsantes, A.E.9
  • 32
  • 41
    • 84923169934 scopus 로고    scopus 로고
    • New genetic loci link adipose and insulin biology to body fat distribution
    • Shungin D, Winkler TW, Croteau-Chonka DC, Ferreira T, Locke AE, Magi R, Strawbridge RJ, Pers TH, Fischer K, Justice AE, Workalemahu T, Wu JM, Buchkovich ML, Heard-Costa NL, Roman TS, Drong AW, Song C, Gustafsson S, Day FR, Esko T, Fall T, Kutalik Z, Luan J, Randall JC, Scherag A, Vedantam S, Wood AR, Chen J, Fehrmann R, Karjalainen J, Kahali B, Liu CT, Schmidt EM, Absher D, Amin N, Anderson D, Beekman M, Bragg-Gresham JL, Buyske S, Demirkan A, Ehret GB, Feitosa MF, Goel A, Jackson AU, Johnson T, Kleber ME, Kristiansson K, Mangino M, Mateo Leach I, Medina-Gomez C, Palmer CD, Pasko D, Pechlivanis S, Peters MJ, Prokopenko I, Stancakova A, Ju Sung Y, Tanaka T, Teumer A, Van Vliet-Ostaptchouk JV, Yengo L, Zhang W, Albrecht E, Arnlov J, Arscott GM, Bandinelli S, Barrett A, Bellis C, Bennett AJ, Berne C, Bluher M, Bohringer S, Bonnet F, Bottcher Y, Bruinenberg M, Carba DB, Caspersen IH, Clarke R, Daw EW, Deelen J, Deelman E, Delgado G, Doney AS, Eklund N, Erdos MR, Estrada K, Eury E, Friedrich N, Garcia ME, Giedraitis V, Gigante B, Go AS, Golay A, Grallert H, Grammer TB, Grassler J, Grewal J, Groves CJ, Haller T, Hallmans G, Hartman CA, Hassinen M, Hayward C, Heikkila K, Herzig KH, Helmer Q, Hillege HL, Holmen O, Hunt SC, Isaacs A, Ittermann T, James AL, Johansson I, Juliusdottir T, Kalafati IP, Kinnunen L, Koenig W, Kooner IK, Kratzer W, Lamina C, Leander K, Lee NR, Lichtner P, Lind L, Lindstrom J, Lobbens S, Lorentzon M, Mach F, Magnusson PK, Mahajan A, McArdle WL, Menni C, Merger S, Mihailov E, Milani L, Mills R, Moayyeri A, Monda KL, Mooijaart SP, Muhleisen TW, Mulas A, Muller G, Muller-Nurasyid M, Nagaraja R, Nalls MA, Narisu N, Glorioso N, Nolte IM, Olden M, Rayner NW, Renstrom F, Ried JS, Robertson NR, Rose LM, Sanna S, Scharnagl H, Scholtens S, Sennblad B, Seufferlein T, Sitlani CM, Vernon Smith A, Stirrups K, Stringham HM, Sundstrom J, Swertz MA, Swift AJ, Syvanen AC, Tayo BO, Thorand B, Thorleifsson G, Tomaschitz A, Troffa C, van Oort FV, Verweij N, Vonk JM, Waite LL, Wennauer R, Wilsgaard T, Wojczynski MK, Wong A, Zhang Q, Hua Zhao J, Brennan EP, Choi M, Eriksson P, Folkersen L, Franco-Cereceda A, Gharavi AG, Hedman AK, Hivert MF, Huang J, Kanoni S, Karpe F, Keildson S, Kiryluk K, Liang L, Lifton RP, Ma B, McKnight AJ, McPherson R, Metspalu A, Min JL, Moffatt MF, Montgomery GW, Murabito JM, Nicholson G, Nyholt DR, Olsson C, Perry JR, Reinmaa E, Salem RM, Sandholm N, Schadt EE, Scott RA, Stolk L, Vallejo EE, Westra HJ, Zondervan KT; Consortium AD, Consortium CAD, Consortium CK, Consortium G, Consortium G, Glgc, Icbp, International Endogene C, LifeLines Cohort S, Investigators M, Mu TC, Consortium P, ReproGen C, Amouyel P, Arveiler D, Bakker SJ, Beilby J, Bergman RN, Blangero J, Brown MJ, Burnier M, Campbell H, Chakravarti A, Chines PS, Claudi-Boehm S, Collins FS, Crawford DC, Danesh J, de Faire U, de Geus EJ, Dorr M, Erbel R, Eriksson JG, Farrall M, Ferrannini E, Ferrieres J, Forouhi NG, Forrester T, Franco OH, Gansevoort RT, Gieger C, Gudnason V, Haiman CA, Harris TB, Hattersley AT, Heliovaara M, Hicks AA, Hingorani AD, Hoffmann W, Hofman A, Homuth G, Humphries SE, Hypponen E, Illig T, Jarvelin MR, Johansen B, Jousilahti P, Jula AM, Kaprio J, Kee F, Keinanen-Kiukaanniemi SM, Kooner JS, Kooperberg C, Kovacs P, Kraja AT, Kumari M, Kuulasmaa K, Kuusisto J, Lakka TA, Langenberg C, Le Marchand L, Lehtimaki T, Lyssenko V, Mannisto S, Marette A, Matise TC, McKenzie CA, McKnight B, Musk AW, Mohlenkamp S, Morris AD, Nelis M, Ohlsson C, Oldehinkel AJ, Ong KK, Palmer LJ, Penninx BW, Peters A, Pramstaller PP, Raitakari OT, Rankinen T, Rao DC, Rice TK, Ridker PM, Ritchie MD, Rudan I, Salomaa V, Samani NJ, Saramies J, Sarzynski MA, Schwarz PE, Shuldiner AR, Staessen JA, Steinthorsdottir V, Stolk RP, Strauch K, Tonjes A, Tremblay A, Tremoli E, Vohl MC, Volker U, Vollenweider P, Wilson JF, Witteman JC, Adair LS, Bochud M, Boehm BO, Bornstein SR, Bouchard C, Cauchi S, Caulfield MJ, Chambers JC, Chasman DI, Cooper RS, Dedoussis G, Ferrucci L, Froguel P, Grabe HJ, Hamsten A, Hui J, Hveem K, Jockel KH, Kivimaki M, Kuh D, Laakso M, Liu Y, Marz W, Munroe PB, Njolstad I, Oostra BA, Palmer CN, Pedersen NL, Perola M, Perusse L, Peters U, Power C, Quertermous T, Rauramaa R, Rivadeneira F, Saaristo TE, Saleheen D, Sinisalo J, Slagboom PE, Snieder H, Spector TD, Thorsteinsdottir U, Stumvoll M, Tuomilehto J, Uitterlinden AG, Uusitupa M, van der Harst P, Veronesi G, Walker M, Wareham NJ, Watkins H, Wichmann HE, Abecasis GR, Assimes TL, Berndt SI, Boehnke M, Borecki IB, Deloukas P, Franke L, Frayling TM, Groop LC, Hunter DJ, Kaplan RC, O'Connell JR, Qi L, Schlessinger D, Strachan DP, Stefansson K, van Duijn CM, Willer CJ, Visscher PM, Yang J, Hirschhorn JN, Zillikens MC, McCarthy MI, Speliotes EK, North KE, Fox CS, Barroso I, Franks PW, Ingelsson E, Heid IM, Loos RJ, Cupples LA, Morris AP, Lindgren CM, Mohlke KL. New genetic loci link adipose and insulin biology to body fat distribution. Nature. 2015;518:187-196.
    • (2015) Nature , vol.518 , pp. 187-196
    • Shungin, D.1    Winkler, T.W.2    Croteau-Chonka, D.C.3    Ferreira, T.4    Locke, A.E.5    Magi, R.6    Strawbridge, R.J.7    Pers, T.H.8    Fischer, K.9    Justice, A.E.10    Workalemahu, T.11    Wu, J.M.12    Buchkovich, M.L.13    Heard-Costa, N.L.14    Roman, T.S.15    Drong, A.W.16    Song, C.17    Gustafsson, S.18    Day, F.R.19    Esko, T.20    more..
  • 44
    • 84949998712 scopus 로고    scopus 로고
    • Combining information on multiple instrumental variables in Mendelian randomization: comparison of allele score and summarized data methods
    • Burgess S, Dudbridge F, Thompson SG. Combining information on multiple instrumental variables in Mendelian randomization: comparison of allele score and summarized data methods. Stat Med. 2016;35:1880-1906.
    • (2016) Stat Med , vol.35 , pp. 1880-1906
    • Burgess, S.1    Dudbridge, F.2    Thompson, S.G.3
  • 47
    • 84959903925 scopus 로고    scopus 로고
    • Mendelian randomization to assess causal effects of blood lipids on coronary heart disease: lessons from the past and applications to the future
    • Burgess S, Harshfield E. Mendelian randomization to assess causal effects of blood lipids on coronary heart disease: lessons from the past and applications to the future. Curr Opin Endocrinol Diabetes Obes. 2016;23:124-130.
    • (2016) Curr Opin Endocrinol Diabetes Obes , vol.23 , pp. 124-130
    • Burgess, S.1    Harshfield, E.2
  • 49
    • 0028901713 scopus 로고
    • Allele-specific increase in basal transcription of the plasminogen-activator inhibitor 1 gene is associated with myocardial infarction
    • Eriksson P, Kallin B, van't Hooft FM, Bavenholm P, Hamsten A. Allele-specific increase in basal transcription of the plasminogen-activator inhibitor 1 gene is associated with myocardial infarction. Proc Natl Acad Sci USA. 1995;92:1851-1855.
    • (1995) Proc Natl Acad Sci USA , vol.92 , pp. 1851-1855
    • Eriksson, P.1    Kallin, B.2    van't Hooft, F.M.3    Bavenholm, P.4    Hamsten, A.5
  • 50
    • 79955922341 scopus 로고    scopus 로고
    • Plasminogen activator inhibitor-1 deficient mice are protected from angiotensin II-induced fibrosis
    • Beier JI, Kaiser JP, Guo L, Martinez-Maldonado M, Arteel GE. Plasminogen activator inhibitor-1 deficient mice are protected from angiotensin II-induced fibrosis. Arch Biochem Biophys. 2011;510:19-26.
    • (2011) Arch Biochem Biophys , vol.510 , pp. 19-26
    • Beier, J.I.1    Kaiser, J.P.2    Guo, L.3    Martinez-Maldonado, M.4    Arteel, G.E.5
  • 53
    • 84899444073 scopus 로고    scopus 로고
    • Plasminogen activator inhibitor-1 deficiency ameliorates insulin resistance and hyperlipidemia but not bone loss in obese female mice
    • Tamura Y, Kawao N, Yano M, Okada K, Matsuo O, Kaji H. Plasminogen activator inhibitor-1 deficiency ameliorates insulin resistance and hyperlipidemia but not bone loss in obese female mice. Endocrinology. 2014;155:1708-1717.
    • (2014) Endocrinology , vol.155 , pp. 1708-1717
    • Tamura, Y.1    Kawao, N.2    Yano, M.3    Okada, K.4    Matsuo, O.5    Kaji, H.6
  • 56
    • 0033323792 scopus 로고    scopus 로고
    • Hormonal control of plasminogen activator inhibitor-1 gene expression and production in human adipose tissue: stimulation by glucocorticoids and inhibition by catecholamines
    • Halleux CM, Declerck PJ, Tran SL, Detry R, Brichard SM. Hormonal control of plasminogen activator inhibitor-1 gene expression and production in human adipose tissue: stimulation by glucocorticoids and inhibition by catecholamines. J Clin Endocrinol Metab. 1999;84:4097-4105.
    • (1999) J Clin Endocrinol Metab , vol.84 , pp. 4097-4105
    • Halleux, C.M.1    Declerck, P.J.2    Tran, S.L.3    Detry, R.4    Brichard, S.M.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.